Neoadjuvant Treatment Pegylated Liposomal Doxorubicin Plus Cyclophosphamide Sequential Docetaxel Plus Trastuzumab and Pertuzumab Versus Docetaxel Plus Carboplatin Combined With Trastuzumab and Pertuzumab in HER-2 Positive Breast Cancer
Clinical trial NCT05159193 · RECRUITING
Trial details
- NCT number
- NCT05159193
- Sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-20
- Primary completion
- 2024-10-30
- Enrollment
- 372
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.